4.7 Review

Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID

Related references

Note: Only part of the references are listed.
Review Immunology

Role of natural killer and B cell interaction in inducing pathogen specific immune responses

Nikunj Tandel et al.

Summary: Human natural killer cells (hNKs) and other ILCs interact with B cells to induce pathogen-specific immune responses and play a crucial role in clearing infectious pathogens in diseases.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2023)

Article Infectious Diseases

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID

Benjamin Giszas et al.

Summary: This study investigated long-term symptoms and quality of life (QoL) after SARS-CoV-2 infection, finding that only about one-third of patients experienced a significant reduction in QoL, while the rest had a near-normal QoL. This suggests a differentiation between post-COVID disease and post-COVID condition.

INFECTION (2023)

Review Immunology

Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

Vivek P. Chavda et al.

Summary: The zoonotic SARS-CoV-2 virus undergoes evolution, adaptation, and selection to develop variants that result in the pandemic. The spike protein, required for binding to host cells, has a high propensity for mutations, generating numerous variants. Hybrid variants can also be produced through recombination of genomic sequences from two different lineages of the virus. Genome sequencing is the most accurate approach for identifying the hybrid variants, while immunological diagnostic assays provide insight into their pathogenesis and reactions.

VACCINES (2023)

Review Immunology

Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines

Manish Dhawan et al.

Summary: The emergence of novel variants of SARS-CoV-2 and their ability to evade the immune response makes it essential to understand the mechanisms of interaction between the virus and the human immune system. This understanding is crucial for the development of effective vaccines against COVID-19. T cells play a critical role in reducing viral load and containing the infection, but their hyperactivation and reduced numbers are associated with severe disease. The involvement of T cells in determining the prognosis of SARS-CoV-2 infection and the strategies to enhance T cell-mediated immune responses are still not fully understood.

VACCINES (2023)

Review Immunology

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms

Brent Brown et al.

Summary: The COVID-19 pandemic is caused by the SARS-CoV-2 virus. The immune system plays a crucial role in fighting against viral infections. The development of single cell sequencing and other laboratory techniques provides valuable insights into immune cell characterization and autoimmune conditions.

VACCINES (2023)

Article Medicine, Research & Experimental

The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children

Mehdi Benamar et al.

Summary: Multisystem inflammatory syndrome in children (MIS-C) is a disease that develops in some pediatric patients following acute infection with SARS-CoV-2 through unknown mechanisms. Tregs in MIS-C are destabilized through a Notch1-dependent mechanism. Genetic analysis revealed enrichment of rare deleterious variants affecting inflammation and autoimmunity pathways in MIS-C patients, including dominant-negative mutations in the Notch1 regulators NUMB and NUMBL leading to Notch1 upregulation. Notch1 signaling in Tregs induces CD22, disrupting their stability in an mTORC1-dependent manner and promoting systemic inflammation. These findings highlight the Notch1/CD22 signaling axis as a crucial factor in Treg dysfunction in MIS-C and suggest distinct immune checkpoints controlled by individual Treg Notch receptors that influence the inflammatory outcome in SARS-CoV-2 infection.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Medicine, General & Internal

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

Feargal J. Ryan et al.

Summary: A study found that recovered individuals, even those with mild cases, may experience persistent symptoms for months after infection, known as long COVID. An integrated analysis of 69 patients recovering from COVID-19 revealed variations in cellular and gene expression levels that may explain the persistence of these long-term effects.

BMC MEDICINE (2022)

Article Immunology

HLA-dependent variation in SARS-CoV-2 CD8 (+) T cell cross-reactivity with human coronaviruses

Paul R. Buckley et al.

Summary: This study explores the cross-protective immunity between SARS-CoV-2 and common-cold human coronaviruses and identifies several highly similar immunogenic peptides. The study also suggests that the distribution of specific TCRs in COVID-19 patients may be HLA-dependent. Additionally, the study provides several conserved SARS-CoV-2 peptides that are recognized by a high proportion of the global population.

IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis

Caroline Busatta Vaz de Paula et al.

Summary: Acute respiratory distress syndrome (ARDS) followed by lung remodeling is observed in COVID-19, which can lead to pulmonary fibrosis. Therapy with TGF-beta inhibitors may mitigate the development of pulmonary fibrosis and its consequences for post-COVID-19 life quality.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Virology

Assessment of CD39 expression in regulatory T-cell subsets by disease severity in adult and juvenile COVID-19 cases

Abdurrahman Simsek et al.

Summary: This study investigated the role of CD39 expression in Treg cell subsets in COVID-19 immunopathogenesis and found that CD39(+) Tregs increased with disease severity in adult patients, while they decreased in an age-dependent manner in juvenile patients.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

Review Immunology

Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry

Brianna R. Traxinger et al.

Summary: Tregs are essential for preventing autoimmune diseases and maintaining immune balance, while also exhibiting tissue-specific functions and dynamic roles within different tissue compartments.

MUCOSAL IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron

Jinyan Liu et al.

Summary: This study demonstrates that cellular immunity induced by current SARS-CoV-2 vaccines is highly conserved to the Omicron spike protein. Individuals vaccinated with Ad26.COV2.S or BNT162b2 vaccines showed durable spike-specific CD8(+) and CD4(+) T cell responses that were cross-reactive to both the Delta and Omicron variants, including in central and effector memory cellular subpopulations.

NATURE (2022)

Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Article Immunology

Peculiarities of the T Cell Immune Response in COVID-19

Dmitry Kudlay et al.

Summary: Understanding the immune response to SARS-CoV-2, especially the T cell response, is crucial for vaccine development and disease control strategies. This review summarizes studies on the immune response to coronavirus infections, provides insights into T cell components, and presents the most informative methods for assessing the immune response to SARS-CoV-2 infection.

VACCINES (2022)

Review Medicine, General & Internal

Regulatory T Cells in Immunopathogenesis and Severity of COVID-19: A Systematic Review

Sam Alahyari et al.

Summary: This study evaluated the role of regulatory T cells (Tregs) in COVID-19. Currently, there is no consensus on the increase or decrease of Tregs in COVID-19 patients compared to the control group. However, it was observed that Tregs in severe COVID-19 patients were significantly lower than moderate patients, resulting in uncontrolled inflammation and cytokine storm.

ARCHIVES OF IRANIAN MEDICINE (2022)

Article Biochemistry & Molecular Biology

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

David J. Ahern et al.

Summary: The study presents a comprehensive blood atlas for patients with varying severity of COVID-19, compared to influenza, sepsis patients, and healthy volunteers. The results identify immune signatures and correlates of host response, including cells, inflammatory mediators, immune repertoire, and metabolic and coagulation features. The study also reveals that persistent immune activation is a specific feature of COVID-19. Plasma proteomic analysis enables sub-phenotyping and prediction of severity and outcome. Integrative analyses show feature groupings linked with severity and specificity compared to influenza and sepsis.
Article Cell Biology

Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals

Anuradha Rajamanickam et al.

Summary: This study investigated the composition of T cell subsets in convalescent individuals of SARS-CoV2 infection and found alterations in lymphocyte counts, memory T cell subset frequencies, and common gamma-chain cytokines during the recovery process.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Review Multidisciplinary Sciences

The immunology and immunopathology of COVID-19

Miriam Merad et al.

Summary: Considerable research effort has been focused on deciphering the immune response to SARS-CoV-2 infections and understanding the pathophysiology of COVID-19, including Long Covid syndrome. The hope is that knowledge gained from this research will be applied to studies of inflammatory processes in critical and chronic illnesses in the future.

SCIENCE (2022)

Article Multidisciplinary Sciences

Persistent COVID-19 symptoms in a community study of 606,434 people in England

Matthew Whitaker et al.

Summary: This study characterizes Long COVID using data from the REACT-2 community-based study in England, estimating the prevalence of persistent symptoms and identifying risk factors. It also finds evidence of symptom clustering.

NATURE COMMUNICATIONS (2022)

Review Biotechnology & Applied Microbiology

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges

Tapas Kumar Goswami et al.

Summary: This article discusses the mechanism of autoimmune diseases and the crucial role of regulatory T cells (Tregs). Tregs control immune suppression by regulating various immune cells, protecting the body from the impact of autoimmune diseases. Studying T cell markers and therapeutic approaches can help reduce the severity of autoimmune-related conditions.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Immunology

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers

Miguel Galan et al.

Summary: Long-COVID is a syndrome characterized by persistent symptoms and signs of COVID-19 even after weeks or months of infection. The underlying mechanisms are unclear, but immune dysregulation and certain clinical and demographic factors may contribute to the development of this condition. Accurate diagnostic biomarkers can help improve the management of Long-COVID patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients

Mercedes Garcia-Gasalla et al.

Summary: This study identified a hyperinflammatory state with significantly elevated neutrophil/lymphocyte ratio, ferritin, IL-1Ra, sIL-2r alpha, and IL-18 levels, as well as a low T1 lymphocyte signature in severe/critical COVID-19 patients.

FRONTIERS IN MEDICINE (2022)

Review Medicine, Research & Experimental

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?

Manish Dhawan et al.

Summary: The Omicron variant is a highly mutated and contagious strain of SARS-CoV-2. Its increased affinity to host receptors due to spike protein mutations has led to reduced vaccine efficacy. It has become the dominant variant in several countries and potential recombination with other variants poses a major threat to humanity.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Urology & Nephrology

Characterization of regulatory T cells in SARS-CoV-2 infected hemodialysis patients: relation to clinical and radiological severity

Emad Samaan et al.

Summary: This study demonstrates the decline of T-cell, particularly T-regulatory cell, in patients infected with SARS-CoV-2, and suggests that hemodialysis does not distinctly impact the T-cell response. Hemodialysis patients showed higher CD39+ Treg cell count and better clinical features, indicating a potential protective effect.

BMC NEPHROLOGY (2022)

Review Virology

The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update

Saade Abdalkareem Jasim et al.

Summary: The interaction between the immune system and SARS-CoV-2 is crucial for understanding COVID-19 pathogenesis and developing therapeutic tools. Different immune components play various roles in viral infections, and characterizing the immune reactions is essential for defining the pathogenicity of COVID-19. Furthermore, investigating the roles of other immune mediators in the immunopathogenesis of COVID-19 is necessary.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Immunology

A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?

Simon Haunhorst et al.

Summary: This scoping review summarizes the existing literature on the frequency and functionality of Tregs in convalescent COVID-19 patients. The reviewed studies suggest that Treg population can recover quantitatively and functionally during recovery, but infection-induced dysregulation may persist for several months. Even in Long COVID patients almost one year post-infection, Treg proportions are significantly altered, indicating their potential involvement in immune system-associated sequelae.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study

Aranka V Ballering et al.

LANCET (2022)

Article Virology

Regulatory T Cells Decreased during Recovery from Mild COVID-19

Purilap Seepathomnarong et al.

Summary: This study investigated the dynamic changes and cytokine production of regulatory T cells (Tregs) in patients with mild COVID-19. The results showed an increase in the percentage of Treg cells during active infection, and CD25(+)CD127(low) T cells produced IL-10 and TGF-beta, especially with N peptide stimulation. In addition, S1 peptide stimulation induced a higher IFN-gamma-secreting CD8(+) T-cell response compared to N peptide stimulation. These findings suggest that Tregs have an important role in regulating inflammatory responses in mild SARS-CoV-2 infection, and novel vaccine development should consider enhancing T-cell repertoires.

VIRUSES-BASEL (2022)

Article Immunology

Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection

Milena Wiech et al.

Summary: Some COVID-19 convalescents suffer from post-acute COVID syndrome (PACS)/long COVID, and it is important to understand the cellular and molecular mechanisms as well as potential predictors of their long-term responses. The immune system and T cell alterations are proposed as drivers of post-acute COVID syndrome, with severity and time having different effects on T cell subsets.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection

Zhan Xu et al.

Summary: The COVID-19 pandemic has caused severe global impact, with activated immune response as a key feature. Regulatory T cells play a crucial role in suppressing inflammatory response and tissue repair. Research on the changes of FOXP3(+) Tregs in COVID-19 patients, their relationship with disease severity, and the potential role of FOXP3(+) Tregs in SARS-CoV-2 infection are discussed.

FRONTIERS IN IMMUNOLOGY (2022)

Review Public, Environmental & Occupational Health

MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review

Jivan Qasim Ahmed et al.

Summary: miRNAs have potential therapeutic targets in combating COVID-19, reducing viral load, and mitigating the deleterious consequences of excessive cytokine secretion.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Review Immunology

Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment

Bayley R. McRitchie et al.

Summary: The concept of cancer immunotherapy has made significant progress, but challenges related to the relationship between CD4(+) T cells and CD8(+) T cells and the immunosuppressive actions of Treg cells still require attention.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities

Murad Alahdal et al.

Summary: The exhaustion of immune cells in COVID-19 is a serious concern and the dysregulation of immune cell functionality may lead to inflammation and cytokine storm, which explains the failure of vaccines to induce sufficient antiviral responses. Understanding the processes of immune cell over-activation and exhaustion is crucial for developing novel immune intervention strategies.

CLINICAL IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

ACE2-independent infection of T lymphocytes by SARS-CoV-2

Xu-Rui Shen et al.

Summary: This study confirmed that T cells can be infected by SARS-CoV-2 in a spike-ACE2-independent manner. This finding provides new insights into the underlying mechanisms of SARS-CoV-2-induced lymphopenia in COVID-19 patients.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Allergy

Compartmental immunophenotyping in COVID-19 ARDS: A case series

Andreas Ronit et al.

Summary: In critically ill patients with COVID-19 ARDS, there is a distinct immunological profile in the lungs, characterized by a dominance of immature neutrophils, lymphopenia of CD4 and CD8 T cells, and higher fractions of regulatory T cells and TH17 cells. The lung exhibits a heavily hyperinflammatory environment with upregulation of activation markers on CD4 and CD8 T cells and macrophages, along with high levels of various cytokines such as IL-1RA, IL-6, IL-8, IP-10, and MCP-1.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Cell Biology

Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls

Armin Sadeghi et al.

Summary: In COVID-19 patients, an increase in Th17 cells and decrease in Treg cells are associated with hyperinflammation and disease progression, with a higher inflammatory ratio observed in deceased patients compared to those who improved, indicating the critical role of inflammation in patient mortality.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Allergy

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Bernhard Kratzer et al.

Summary: The study revealed that COVID-19 convalescent patients still exhibit a range of immune system changes, including reduced neutrophils, increased activation of T cells, and elevated levels of specific antibodies even ten weeks after infection. Additionally, there were correlations found between these immunological changes and clinical/demographic parameters.

ALLERGY (2021)

Article Allergy

SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency

Sudhir Gupta et al.

Summary: The study examined subsets of CD4+ and CD8+ T cells, B cells, and regulatory lymphocytes in an immunocompetent patient and a CVID patient, revealing different patterns of abnormalities. The immunocompetent patient showed greater changes in various subsets compared to the CVID patient, indicating different immunological responses to SARS-CoV-2 infection.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)

Editorial Material Genetics & Heredity

An update to novel therapeutic approaches for treatment of COVID-19

Nikoo Hossein-khannazer et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Review Cardiac & Cardiovascular Systems

Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians

Sabrina Setembre Batah et al.

Summary: COVID-19 caused by SARS-CoV-2 is a global pandemic, with patients progressing from flu-like symptoms to severe acute lung injury characterized by acute and diffuse inflammatory damage to the alveolar-capillary barrier.

RESPIRATORY MEDICINE (2021)

Article Medicine, Research & Experimental

Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19

Meng-En Zhu et al.

Summary: The study demonstrated the potential therapeutic effect of recombinant human interleukin-2 (rIL-2) as an adjuvant therapy for patients with severe COVID-19, which may be mediated by increasing lymphocyte numbers.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Immunology

Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Michael J. Peluso et al.

Summary: This study found that persistent immune activation may be associated with ongoing symptoms following COVID-19, with cytokine levels during early recovery period being related to the development of PASC. This suggests potential therapeutic targets for those experiencing PASC.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Medicine, Research & Experimental

The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy

Suhana Ahmad et al.

Summary: COVID-19 is a complex disease with various manifestations, primarily affecting the lungs and potentially other organs, with immune dysregulation contributing to disease severity. Regulatory T cells (Tregs) and their hallmark TNFR2 are suggested to play a significant role in COVID-19 management.

LIFE SCIENCES (2021)

Article Immunology

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Peter A. Szabo et al.

Summary: This study investigated the immune responses in the respiratory tract and blood of severe COVID-19 patients, revealing that T cells in the airways showed protective profiles while myeloid cells exhibited hyperinflammatory signatures. These findings provide important insights for understanding and treating COVID-19 lung pathology.

IMMUNITY (2021)

Article Immunology

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Nina Le Bert et al.

Summary: The efficacy of virus-specific T cells in clearing pathogens involves a delicate balance between antiviral and inflammatory responses. Asymptomatic individuals clearing SARS-CoV-2 showed increased production of IFN-gamma and IL-2, along with a proportional secretion of IL-10 and proinflammatory cytokines, while symptomatic individuals displayed a disproportionate secretion of inflammatory cytokines triggered by SARS-CoV-2-specific T cell activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice

Rajeev K. Tyagi et al.

Summary: Regulatory T cells play a crucial role in maintaining immune homeostasis in the intestine, and dysfunction of T-reg cells is linked to various inflammatory and autoimmune disorders. Treatment with low-dose IL-2 may be a promising therapeutic strategy for inflammatory conditions, but its effectiveness in treating IBD is still uncertain.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell Biology

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

Bing Sun et al.

Summary: A study showed increased levels of plasma cytokines and nEV proteins in individuals recovering from COVID-19, potentially leading to neuronal dysfunction, especially in patients with neurological issues and those recovering from the infection. Longitudinal studies are needed to monitor these biomarkers to assess neural damage and systemic effects.

CELLS (2021)

Article Microbiology

Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens

Ryuta Uraki et al.

Summary: This study showed that transient Treg-cell depletion without adjuvants in mice induced protective antigen-specific immunity to SARS-CoV-2, including the production of antibodies and cellular immune responses. The manipulation of Treg cells could activate antigen-presenting DCs, offering an innovative approach to vaccine design for SARS-CoV-2 and emerging variants.

PLOS PATHOGENS (2021)

Article Immunology

Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients

Sara Caldrer et al.

Summary: The study revealed a significant association between CD4(+) T cell dysregulation and the severity and progression of COVID-19. Analysing baseline regulatory T cell levels can predict clinical worsening during hospitalization, aiding in better clinical stratification and patient management.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults

Maria Raffaella Petrara et al.

Summary: The immune response in pediatric and adult patients infected with SARS-CoV-2 differs, with adults showing higher levels of immune activation and lower production of antibodies, while children have higher levels of regulatory cells. The higher expression of regulatory cells in children may contribute to reduce immune activation, leading to a stronger specific response against the virus.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections

Hani Harb et al.

Summary: This study demonstrates that increased expression of Notch4 on Treg cells in COVID-19 patients is associated with disease severity, and inhibition of Notch4 can help restore immune dysregulation and reduce disease morbidity and mortality.

IMMUNITY (2021)

Article Multidisciplinary Sciences

A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections

Sarah C. Vick et al.

Summary: Recent research comparing the immune response in patients with SARS-CoV-2, influenza, and RSV found similarities in the immune landscape, with distinct changes in T-reg cells associated with COVID-19 severity. These findings suggest potential therapeutic use of T-regs to combat severe inflammation in COVID-19 patients, and highlight the importance of leveraging existing knowledge of flu and RSV infections to identify common treatment strategies.

SCIENCE ADVANCES (2021)

Article Biochemistry & Molecular Biology

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID

Alberto Utrero-Rico et al.

Summary: Patients with persistent symptoms after acute SARS-CoV-2 infection showed perturbed distribution of circulating mononuclear cell populations and a pro-inflammatory phenotype. Corticosteroid treatment led to immune alterations reverting to normal, correlating with clinical improvement.

BIOMEDICINES (2021)

Article Multidisciplinary Sciences

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation

Gerdien Mijnheer et al.

Summary: The study illustrates the effector characteristics of human Treg cells under inflammatory conditions and their epigenetic influences, indicating that inflammation-derived Treg cells have specific features and are fine-tuned by environmental adaptations.

NATURE COMMUNICATIONS (2021)

Review Immunology

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm

Ali A. Rabaan et al.

Summary: COVID-19, caused by SARS-CoV-2, is a severe pandemic with unknown complications. The disease leads to a cytokine storm and severe complications like multiple organ failure, acute respiratory distress, and pneumonia. Elderly individuals are at higher risk of complications, while the survival rate is relatively higher compared to other chronic diseases.

VACCINES (2021)

Article Medicine, General & Internal

Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome

Marcus Ståhlberg et al.

AMERICAN JOURNAL OF MEDICINE (2021)

Article Immunology

Different T cell related immunological profiles in COVID-19 patients compared to healthy controls

Armin Mahmoud Salehi Khesht et al.

Summary: In severe cases of COVID-19, there is a significant increase in Th1 and Th17 cells, along with a decrease in Th2 and Treg cells. This is accompanied by a sharp increase in IL-17 and IFN-gamma secretion and a decrease in IL-10 and IL-4 secretion. Additionally, the inhibitory activity of Treg cells is reduced in severe patients.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges

Mehrdad Hefazi et al.

Summary: This review provides the latest preclinical and clinical data on Treg cell therapy in the context of GVHD, highlighting the importance of T cell therapy in preventing and treating GVHD, and discussing future research directions and challenges.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Letter Virology

Post-COVID-19 complications: Multisystemic approach

Tarun K. Suvvari et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Medicine, Research & Experimental

Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS)

Arezoo Hosseini et al.

Summary: Ruxolitinib ameliorated the severity of EAE by modulating the balance between Th17 cells and Tregs, reducing inflammatory markers levels and increasing levels of anti-inflammatory cytokines.

LIFE SCIENCES (2021)

Article Multidisciplinary Sciences

Profound Treg perturbations correlate with COVID-19 severity

Silvia Galvan-Pena et al.

Summary: Severe COVID-19 is characterized by an uncontrolled inflammatory response, potentially linked to dysregulation in T regulatory cells (Treg) which may suppress antiviral T cell responses and have a direct proinflammatory role.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Virology

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity

Takeshi Morita et al.

Summary: The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread, and the major protease 3CLpro of SARS-CoV-2 is an important target for antiviral drug development. ATRA has been identified as an inhibitor of 3CLpro and has shown antiviral effects against SARS-CoV-2 and its variants of concern.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Peripheral and lung resident memory T cell responses against SARS-CoV-2

Judith Grau-Exposito et al.

Summary: The study suggests that lung resident memory T cells play a crucial role in limiting the spread of SARS-CoV-2 and COVID-19. Different clinical outcomes are associated with distinct virus-specific T cell responses, and the persistence of antiviral lung T-RM cells in convalescent patients may help limit reinfection.

NATURE COMMUNICATIONS (2021)

Article Immunology

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning

Bruce K. Patterson et al.

Summary: CCR5 and its ligands play a role in COVID-19 pathogenesis, with a focus on immune responses. Elevated B-cells and certain monocytic subsets were observed in COVID-19 patients, while certain T-cell subsets were decreased compared to healthy controls. Various cytokines showed significantly different levels in COVID-19 patients compared to healthy controls, indicating immune dysregulation in the disease process.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Activation of Cytotoxic Lymphocytes and Presence of Regulatory T Cells in the Trachea of Non-Vaccinated and Vaccinated Chickens as a Recall to an Infectious Laryngotracheitis Virus (ILTV) Challenge

Daniel Maekawa et al.

Summary: The study evaluated the immune responses in chickens vaccinated with different ILTV vaccines and found that CEO vaccine protection was characterized by early and enhanced CTL responses, while TCO and rHVT-LT vaccines were associated with moderate CTL responses followed by enhanced NK cell response. Tregs increase was only detected in non-vaccinated challenged group to support healing.

VACCINES (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Review Medicine, General & Internal

Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis

Fahad M. Iqbal et al.

Summary: This study aimed to investigate the prevalence of clinical characteristics of acute and chronic post-COVID syndrome, finding that fatigue and dyspnoea were the most prevalent symptoms in acute stage, while fatigue and sleep disturbance were the most prevalent symptoms in chronic stage. However, the overall quality of available evidence is poor, with significant risk of bias.

ECLINICALMEDICINE (2021)

Article Cell Biology

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Michael R. Filbin et al.

Summary: This study analyzed thousands of plasma proteins longitudinally in COVID-19 patients, uncovering immune and non-immune proteins linked to the disease. Dynamic immune-cell-derived and tissue-associated proteins associated with survival were identified. The research proposed a model in which interactions among myeloid, epithelial, and T cells drive tissue damage in severe COVID-19 disease.

CELL REPORTS MEDICINE (2021)

Article Immunology

Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study

Jingyi Yang et al.

Summary: Prolonged SARS-CoV-2 positivity (PP) is associated with suppressed CD8(+) T-cell differentiation, which may serve as an indicator for predicting prolonged positivity in COVID-19 patients. Additionally, PP cohort showed a weaker SARS-CoV-2 N protein-specific IFN-gamma(+) T-cell response and a higher frequency of Tregs.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment

Yifei Wang et al.

Summary: Tregs play a crucial role in COVID-19, influencing disease severity and immunopathology mechanisms. They may help regulate immune responses in the early stages and alleviate organ damage in the later stages.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Immunology

Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19

H. Hou et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Rheumatology

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Lauren A. Henderson et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports

Douglas E. Gladstone et al.

ANNALS OF INTERNAL MEDICINE (2020)

Letter Respiratory System

Potential of regulatory T-cell-based therapies in the management of severe COVID-19

Emmanuel Stephen-Victor et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Letter Immunology

Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients

Yaguang Zhang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Biology

IL18 signaling promotes homing of mature Tregs into the thymus

Cristina Peligero-Cruz et al.

ELIFE (2020)

Article Biochemistry & Molecular Biology

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Benjamin J. Meckiff et al.

Article Cell Biology

Regulatory T cells: Master thieves of the immune system

Billur Akkaya et al.

CELLULAR IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Sara De Biasi et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Treg Enhancing Therapies to Treat Autoimmune Diseases

Peter J. Eggenhuizen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Article Oncology

Immunological features of coronavirus disease 2019 in patients with cancer

Marion Thibaudin et al.

EUROPEAN JOURNAL OF CANCER (2020)

Article Infectious Diseases

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

Lawrence B. Afrin et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Biochemistry & Molecular Biology

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Li Tan et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Immunology

Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19

Julika Neumann et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

Article Urology & Nephrology

A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity

Julia Hagenstein et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Biochemistry & Molecular Biology

A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism

Eleonora Trotta et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types

Angela M. Magnuson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Oncology

Cell-Based Therapies with T Regulatory Cells

Mateusz Gliwinski et al.

BIODRUGS (2017)

Article Biochemistry & Molecular Biology

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Abigail E. Overacre-Delgoffe et al.

Review Immunology

Tissue Tregs

Marisella Panduro et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

Article Biochemistry & Molecular Biology

A Distinct Function of Regulatory T Cells in Tissue Protection

Nicholas Arpaia et al.

Article Multidisciplinary Sciences

The microbiota regulates type 2 immunity through RORγt+ T cells

Caspar Ohnmacht et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus

Yongqiang Feng et al.

Review Immunology

tTregs, pTregs, and iTregs: similarities and differences

Ethan M. Shevach et al.

IMMUNOLOGICAL REVIEWS (2014)

Article Biotechnology & Applied Microbiology

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

Dan Blat et al.

MOLECULAR THERAPY (2014)

Article Biochemistry & Molecular Biology

Pathogenic conversion of Foxp3(+) T cells into T(H)17 cells in autoimmune arthritis

Noriko Komatsu et al.

NATURE MEDICINE (2014)

Article Multidisciplinary Sciences

Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions

Ling Lu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Immunology

Role of regulatory T cells during virus infection

Tamara Veiga-Parga et al.

IMMUNOLOGICAL REVIEWS (2013)

Article Virology

Clearance of influenza virus infections by T cells: risk of collateral damage?

M. L. B. Hillaire et al.

CURRENT OPINION IN VIROLOGY (2013)

Article Endocrinology & Metabolism

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnes Hartemann et al.

LANCET DIABETES & ENDOCRINOLOGY (2013)

Article Multidisciplinary Sciences

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo

Janine Gotot et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Cell Biology

Tregs and infections: on the potential value of modifying their function

Sharvan Sehrawat et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2011)

Article Oncology

The emerging role of CXCL10 in cancer (Review)

Mingli Liu et al.

ONCOLOGY LETTERS (2011)

Article Biochemistry & Molecular Biology

Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells

Zhonghua Yan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Immunology

Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression

Ethan M. Shevach

IMMUNITY (2009)

Article Multidisciplinary Sciences

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis

Graham P. Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Editorial Material Immunology

How do Regulatory T Cells Work?

A. Corthay

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)

Article Medicine, Research & Experimental

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice

Julia Yuen-Shan Tsang et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Multidisciplinary Sciences

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Stephan Sauer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Coordination of early protective immunity to viral infection by regulatory T cells

Jennifer M. Lund et al.

SCIENCE (2008)

Article Immunology

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

Weihong Liu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Review Immunology

Imbalance of regulatory T cells in human autoimmune diseases

C Dejaco et al.

IMMUNOLOGY (2006)

Article Immunology

Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface

AC Zenclussen et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2006)

Article Immunology

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

QZ Tang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Article Immunology

CD4+CD25high regulatory cells in human peripheral blood

C Baecher-Allan et al.

JOURNAL OF IMMUNOLOGY (2001)